Recent Advances in Library Synthesis to Accelerate Medicinal Chemistry Research
Learn how parallel medicinal chemistry (PMC) and high throughput experimentation (HTE) combined with machine learning can provide a more focused approach to target molecules, resulting in a more concentrated set of compounds to make the process of lead selection easier.
Our experts show how PMC can shorten the turnaround time of the design-synthesis-test cycle, providing more compounds with limited scaffolds by using streamlined workflows and accumulated parallel synthesis knowledge.
Check out our comprehensive platform of discovery chemistry services
Related Content
The recent publication in the journal Organic Letters, 'DNA-Compatible Cyclization Reaction to Access 1,3,4-Oxadiazoles & 1,2,4-Triazoles' by our WuXi Biology...
VIEW RESOURCEIntroduction: Targeted Protein Degradation (TPD) has emerged as a promising therapeutic modality due to its potential to develop therapeutics for...
VIEW RESOURCE